GO:0032801 receptor catabolic process: Degradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032801 receptor catabolic process describes the chemical reactions and pathways that break down a receptor molecule, a macromolecule that binds hormones, neurotransmitters, drugs or intracellular messengers to initiate a change in cell function.
• Receptor catabolism controls signal termination, receptor availability and cellular responsiveness, and is often mediated by endosomal-lysosomal trafficking and autophagy-related routes.
• Key molecular players include the transferrin receptor (TFRC), autophagy machinery such as LC3 and ATG proteins, and endosomal sorting complexes that deliver receptors to degradative compartments.
• Dysregulated receptor catabolism contributes to cancer progression, neurofibromatosis-related Schwann cell phenotypes, and immune receptor turnover, making it a target for mechanistic and therapeutic studies.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of receptor catabolic process genes in relevant cell types.
• Studying GO:0032801 requires combining imaging, proteomics, transcriptomics and functional assays to resolve receptor trafficking, degradation and downstream signaling outcomes.
Description
GO:0032801 receptor catabolic process is a biological process term that captures the chemical reactions and pathways resulting in the breakdown of a receptor molecule, defined as a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. Receptors are central to cellular communication, and their controlled destruction is as important as their synthesis and activation. This term therefore sits at the intersection of signal transduction, membrane trafficking and protein turnover. For researchers, receptor catabolic process matters because it determines how long a signal persists, how cells adapt to chronic stimulation, and how receptors are cleared from the cell surface or from intracellular compartments. Defects in receptor breakdown can alter growth factor signaling, immune receptor turnover and neuronal receptor availability, with consequences for cancer, neurodevelopmental and immune-related phenotypes. Because receptor catabolism is mechanistically diverse, it is studied with a wide range of tools, including CRISPR-based gene editing, live-cell imaging, proteomics and transcriptomics. This article summarizes the definition, core mechanisms, key genes, disease links and experimental strategies for GO:0032801, with all factual statements supported by the verified literature listed at the end.
receptor catabolic process At A Glance
| GO ID | GO:0032801 |
|---|---|
| GO term | receptor catabolic process |
| Ontology | biological_process |
| Synonym | receptor breakdown; receptor catabolism; receptor degradation |
| Major function | Breakdown of receptor molecules that bind hormones, neurotransmitters, drugs or intracellular messengers to initiate changes in cell function |
| Related cellular routes | Endosomal-lysosomal trafficking, autophagy-related degradation and receptor sorting pathways |
| Representative receptors | Transferrin receptor (TFRC), IgE receptor FcεRI, odorant receptors and other signaling receptors |
| Disease relevance | Cancer, neurofibromatosis-related Schwann cell biology and immune receptor turnover |
| Research methods | CRISPR editing, imaging, proteomics, transcriptomics and functional degradation assays |
What Is GO:0032801?
In practical terms, GO:0032801 receptor catabolic process refers to the set of biochemical reactions and trafficking pathways that lead to the breakdown of a receptor molecule. The QuickGO definition emphasizes that the receptor is a macromolecule that combines with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function, and that the process results in its breakdown. This includes receptor degradation following ligand binding, constitutive receptor turnover, and the sorting of receptors into degradative compartments such as lysosomes. The term is not limited to a single receptor family; it applies to membrane receptors, intracellular receptors and immune receptors whose catabolism is experimentally documented.
Why Is receptor catabolic process Important in Cell Biology?
Receptor catabolic process is important because it sets the lifetime and abundance of receptors at the cell surface and in intracellular compartments, thereby shaping the strength and duration of cellular responses to hormones, neurotransmitters, drugs and intracellular messengers. When receptor breakdown is perturbed, cells can become hypersensitive or desensitized to signals, and such changes are linked to cancer progression, altered Schwann cell phenotypes and immune receptor dysregulation. Understanding GO:0032801 therefore provides a mechanistic handle on signal termination, receptor recycling and cellular adaptation, and it offers entry points for therapeutic strategies that aim to modulate receptor availability.
• Controls signal duration by removing activated receptors from the cell surface or from signaling compartments.
• Regulates receptor abundance and availability, affecting how cells respond to hormones, neurotransmitters and drugs.
• Connects membrane trafficking and autophagy to receptor turnover and cellular homeostasis.
• Is relevant to cancer biology, where altered receptor catabolism can influence tumor cell signaling and metabolic remodeling.
• Contributes to neurofibromatosis-related phenotypes through effects on Schwann cell behavior and receptor turnover.
• Shapes immune receptor turnover, as illustrated by structural and functional studies of the high-affinity IgE receptor FcεRI.
• Provides a framework for studying receptor degradation in viral entry and receptor-mediated processes.
• Supports development of CRISPR models to test causality of candidate genes in receptor catabolic pathways.
• Enables identification of degradative checkpoints that can be targeted for therapeutic intervention.
• Requires integration of imaging, proteomics and transcriptomics to resolve stage-specific mechanisms.
What Happens During receptor catabolic process?
Receptor activation and entry into the catabolic route
In simple terms: A receptor first binds its signal, and this can trigger the cell to send that receptor to be broken down.
Receptor catabolic process often begins when a receptor engages its ligand or intracellular messenger, which can initiate changes in receptor conformation, post-translational modification and trafficking. For example, the transferrin receptor is a well-studied cargo whose trafficking intersects with autophagosome formation and closure, linking receptor availability to degradative membrane remodeling. In immune receptor biology, structural insights into the high-affinity IgE receptor FcεRI complex have clarified how receptor assembly and engagement can set the stage for downstream turnover. These early events determine whether a receptor is recycled, retained or committed to breakdown.
Sorting into endosomal and degradative compartments
In simple terms: Once marked for destruction, the receptor is sorted into vesicles that carry it toward the cell's degradation machinery.
After activation, receptors can be internalized and sorted through endosomal compartments that direct them toward lysosomal degradation. The transferrin receptor controls both autophagosome formation and closure via phosphatidylinositol 3-phosphate synthesis, illustrating how a receptor can influence the very degradative machinery that processes it. Autophagy-related pathways in yeast and mammalian systems provide conserved mechanistic principles for how cargo is delivered to degradative compartments. This sorting step is a key checkpoint in GO:0032801 because it determines whether a receptor is degraded or returned to the surface.
Autophagy-linked receptor turnover
In simple terms: Some receptors are broken down through autophagy, a self-digestion process that cells use to recycle components.
Autophagy contributes to receptor catabolic process by delivering membrane and cargo to lysosomes for degradation. In yeast, regulatory mechanisms of mitophagy have defined how selective autophagy targets specific cargo, providing a template for understanding receptor degradation routes. In epidermal Langerhans cells, autophagy-regulated lipid metabolism supports cell maintenance, showing that autophagy-dependent degradation pathways can influence specialized cell populations. These findings support the view that receptor catabolism is not a single linear route but a set of convergent degradative mechanisms.
Lysosomal breakdown and signal termination
In simple terms: In the final stage, the receptor is destroyed in the lysosome, which stops its signal.
The terminal step of receptor catabolic process is the breakdown of the receptor molecule, typically in acidic degradative compartments, which terminates signaling and releases constituent amino acids and other breakdown products for reuse. Because the QuickGO definition frames the process as chemical reactions and pathways resulting in receptor breakdown, this step is the defining outcome of GO:0032801. Efficient lysosomal degradation depends on proper delivery of receptors and on the functional integrity of the degradative compartment, as illustrated by studies linking receptor trafficking to autophagosome dynamics. Failure at this stage can prolong signaling and alter cellular responses.
Key Genes Involved in GO:0032801 receptor catabolic process
The following genes and proteins are experimentally implicated in receptor catabolic process or in the trafficking and degradative routes that support it, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TFRC | Transferrin receptor that controls autophagosome formation and closure via phosphatidylinositol 3-phosphate synthesis | Links receptor trafficking to degradative membrane remodeling |
| MAP1LC3B | Autophagy-related protein used as a marker of autophagic membranes | Readout for autophagy-linked receptor turnover |
| ATG5 | Core autophagy machinery component required for autophagosome formation | Functional requirement for autophagy-dependent degradation |
| ATG7 | Autophagy E1-like enzyme involved in LC3 lipidation | Genetic tool for blocking autophagy-linked receptor catabolism |
| SQSTM1 | Selective autophagy receptor that delivers cargo to autophagosomes | Cargo selection in degradative pathways |
| PTPRS | Receptor-type tyrosine phosphatase implicated in Schwann cell epithelial-mesenchymal transition | Receptor turnover and signaling in NF1-related plexiform neurofibromas |
| FCER1A | Alpha subunit of the high-affinity IgE receptor FcεRI complex | Immune receptor assembly and turnover |
| MS4A2 | Beta subunit of the high-affinity IgE receptor FcεRI complex | Structural basis of immune receptor function |
| LINC00842 | Long intergenic non-coding RNA that inactivates PGC-1α and promotes pancreatic cancer malignancy | Metabolic remodeling linked to receptor-related cancer phenotypes |
| PPARGC1A | Transcription co-regulator PGC-1α targeted by LINC00842 | Metabolic and transcriptional control in cancer |
| SLC10A1 | Sodium taurocholate cotransporting polypeptide acting as a functional receptor for hepatitis B and D virus | Receptor-mediated viral entry and turnover |
| ORCO | Odorant receptor co-receptor involved in odorant recognition | Structural and functional model for receptor-ligand interactions |
| LAMP1 | Lysosomal-associated membrane protein used as a marker of degradative compartments | Assessment of lysosomal delivery in receptor catabolism |
| RAB7A | Late endosomal small GTPase controlling trafficking to lysosomes | Regulation of receptor delivery to degradative compartments |
| BECN1 | Beclin-1, a regulator of autophagy initiation | Autophagy-linked receptor degradation |
| ULK1 | Autophagy-initiating kinase downstream of nutrient signaling | Regulation of degradative pathways |
| MTOR | Nutrient-sensing kinase that inhibits autophagy | Upstream regulation of receptor catabolic routes |
How Is receptor catabolic process Regulated?
Receptor catabolic process is regulated at multiple levels, including nutrient sensing, autophagy initiation and endosomal trafficking. The mTOR kinase is a central nutrient-sensitive inhibitor of autophagy, and its activity can therefore suppress autophagy-linked receptor degradation when nutrients are abundant. ULK1 and BECN1 act downstream of nutrient signals to initiate autophagosome formation, which can deliver receptors and other cargo to lysosomes. In specialized cells such as epidermal Langerhans cells, autophagy-regulated lipid metabolism supports maintenance, indicating that metabolic state can influence degradative pathways. The transferrin receptor itself can modulate phosphatidylinositol 3-phosphate synthesis to control autophagosome formation and closure, revealing a feedback layer in which receptor availability influences the degradative machinery. Together, these mechanisms ensure that receptor breakdown is tuned to cellular conditions and signaling demands.
receptor catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LINC00842 | Pancreatic cancer malignancy and metabolic remodeling | Knockout or overexpression in pancreatic cancer cell lines followed by metabolic and transcriptomic profiling |
| PTPRS | NF1-related plexiform neurofibromas and Schwann cell EMT | Knockdown or knockout in Schwann cell models with EMT marker analysis |
| FCER1A | IgE receptor function and allergic signaling | Knock-in or tagged knock-in in immune cell lines for receptor assembly and turnover studies |
| SLC10A1 | Hepatitis B and D virus entry | Knockout in hepatocyte-derived cells followed by viral entry assays |
| TFRC | Receptor trafficking and autophagosome dynamics | Knockout or point-mutation models with imaging of autophagosome formation and closure |
Cancer and metabolic remodeling
Altered receptor catabolism can influence cancer cell signaling and metabolism. LINC00842 inactivates the transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodeling, illustrating how regulatory RNAs and metabolic programs intersect with receptor-related pathways. Because receptor breakdown controls signal duration and receptor abundance, perturbations in GO:0032801 may contribute to sustained oncogenic signaling and metabolic adaptation in tumors.
Neurofibromatosis and Schwann cell biology
Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas, linking a receptor-type tyrosine phosphatase to Schwann cell phenotype and tumor-associated remodeling. This finding supports the idea that receptor turnover and receptor-mediated signaling are relevant to neurofibromatosis-related pathology and that receptor catabolic process genes may modify disease phenotypes.
Immune receptor turnover and allergy
Structural insights into the high-affinity IgE receptor FcεRI complex have clarified how this immune receptor is assembled and engaged, which is directly relevant to its turnover and catabolism. Because FcεRI is central to allergic responses, understanding its catabolic process could inform strategies to modulate receptor availability and downstream immune signaling.
Viral entry and receptor-mediated infection
The sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus, demonstrating that receptor molecules can mediate viral entry and are subject to receptor-mediated trafficking and turnover. Studying receptor catabolic process in this context may help explain how receptor levels influence viral susceptibility and how receptor degradation pathways intersect with infection.
From receptor catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for receptor catabolic process? | CRISPR knockout in a relevant cell line followed by receptor degradation assays |
| Does a specific receptor residue control its breakdown? | Point-mutation knock-in of the receptor gene and measurement of degradation kinetics |
| How does a tagged receptor behave in live cells? | Tagged knock-in of the receptor locus for imaging and proteomics |
| Does overexpression of a receptor or regulator alter catabolism? | Overexpression cell model with quantitative receptor turnover assays |
| Which genes modify autophagy-linked receptor turnover? | CRISPR library screening combined with readouts of receptor abundance |
| How does receptor catabolism change in disease-relevant cells? | Patient-derived or disease-model cells with CRISPR editing and multi-omic profiling |
How to Study the receptor catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Receptor localization and trafficking over time | Tracking internalization and delivery to degradative compartments |
| Immunofluorescence with LAMP1 | Colocalization of receptors with lysosomes | Assessing terminal degradation steps |
| Proteomics | Receptor abundance and interaction partners | Identifying regulators of receptor catabolism |
| RNA-seq | Transcriptional changes linked to receptor turnover | Connecting receptor catabolism to disease programs |
| CRISPR library screening | Genes that modify receptor degradation | Discovery of novel regulators of GO:0032801 |
| Autophagic flux assays | LC3 lipidation and SQSTM1 turnover | Testing autophagy dependence of receptor breakdown |
| Lysosomal function assays | Acidification and degradative capacity | Confirming lysosomal contribution to receptor catabolism |
| Pulse-chase degradation assay | Receptor half-life and degradation kinetics | Quantifying receptor catabolic rates |
Imaging receptor trafficking and degradation
Live-cell and fixed-cell imaging can track receptor localization, internalization and delivery to degradative compartments. Tagged knock-in receptors allow visualization of receptor dynamics without overexpression artifacts, and co-staining with lysosomal markers such as LAMP1 helps define the terminal degradative step. Imaging is particularly useful for distinguishing recycling from degradation and for measuring autophagosome formation and closure in receptor catabolic pathways.
Proteomics and receptor turnover measurements
Proteomic approaches can quantify receptor abundance and identify interaction partners that mediate sorting and degradation. Combining proteomics with pulse-chase or degradation assays provides kinetic information about receptor catabolic process and helps identify rate-limiting steps. These methods are also useful for validating CRISPR phenotypes at the protein level.
Transcriptomics and functional genomics
RNA-seq and functional genomics can reveal transcriptional programs associated with altered receptor catabolism, as illustrated by studies linking LINC00842 and PGC-1α to metabolic remodeling in pancreatic cancer. CRISPR library screening can identify genes that modify receptor degradation when combined with receptor abundance or signaling readouts. These approaches connect GO:0032801 to broader cellular states and disease phenotypes.
Autophagy and lysosomal function assays
Because autophagy contributes to receptor catabolic process, assays for autophagic flux and lysosomal function are essential. LC3 lipidation, SQSTM1 turnover and lysosomal acidification measurements can indicate whether receptor degradation depends on autophagy-linked routes. In specialized cells such as Langerhans cells, autophagy-regulated lipid metabolism can be monitored to link degradative pathways to cell maintenance.
How CRISPR Can Be Used to Study GO:0032801 receptor catabolic process
Knockout
CRISPR knockout is used to remove candidate genes and test whether they are required for receptor catabolic process. For example, knocking out TFRC or autophagy-related genes can reveal effects on receptor trafficking and degradation. Knockout models are also valuable for validating disease-associated genes such as PTPRS in Schwann cell phenotypes.
Point Mutation
Point-mutation models allow precise testing of residues that control receptor sorting, modification or degradation. By introducing disease-relevant or mechanism-probing mutations, researchers can separate receptor function from receptor catabolism and identify sequence features that determine turnover.
Knock-in
Knock-in of tags or reporters at endogenous receptor loci enables physiological expression levels and real-time tracking of receptor catabolic process. Tagged knock-in models are especially useful for imaging receptor delivery to lysosomes and for proteomic enrichment of receptor complexes.
Overexpression
Overexpression models can amplify receptor catabolic pathways to test whether increased receptor or regulator levels alter degradation kinetics and downstream signaling. They are useful for gain-of-function studies and for producing sufficient material for biochemical assays, but results should be interpreted alongside physiological expression models.
How EDITGENE Supports receptor catabolic process Research
Researchers studying receptor catabolic process-related genes often need to determine whether a candidate gene is causally involved in receptor breakdown, whether a specific mutation alters degradation kinetics, or whether a receptor can be tracked at endogenous levels. Addressing these questions requires precise genome editing tools and complementary screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for receptor catabolic process research.
Frequently Asked Questions About receptor catabolic process
What is GO:0032801 receptor catabolic process?
GO:0032801 receptor catabolic process is a biological process term describing the chemical reactions and pathways that result in the breakdown of a receptor molecule, which is a macromolecule that binds hormones, neurotransmitters, drugs or intracellular messengers to initiate a change in cell function.
What genes are involved in receptor catabolic process?
Genes and proteins implicated in receptor catabolic process include TFRC, autophagy-related genes such as ATG5, ATG7, BECN1 and ULK1, cargo receptors such as SQSTM1, and disease-associated factors such as PTPRS and FCER1A.
Why is receptor catabolic process important for cells?
It controls signal duration and receptor abundance, ensuring that cells can terminate responses to hormones, neurotransmitters, drugs and intracellular messengers and adapt to changing conditions.
How is receptor catabolic process linked to cancer?
Altered receptor turnover can influence oncogenic signaling and metabolic remodeling, as illustrated by LINC00842-mediated inactivation of PGC-1α in pancreatic cancer.
Does autophagy contribute to receptor catabolic process?
Yes, autophagy-related pathways deliver cargo to lysosomes and contribute to receptor degradation, as shown by studies of mitophagy regulation and autophagy-dependent cell maintenance.
What methods are used to study receptor catabolic process?
Common methods include live-cell imaging, immunofluorescence with lysosomal markers, proteomics, RNA-seq, autophagic flux assays and CRISPR library screening.
How can CRISPR help study receptor catabolic process?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes and residues that control receptor sorting, degradation and downstream signaling.
Which receptors are well-studied in receptor catabolic process?
The transferrin receptor TFRC and the high-affinity IgE receptor FcεRI are well-studied examples, along with odorant receptors and viral entry receptors such as SLC10A1.
Is receptor catabolic process relevant to immune cells?
Yes, immune receptor turnover is important, and structural studies of FcεRI provide insight into how immune receptors are assembled and can be catabolized.
What diseases are associated with defects in receptor catabolic process?
Diseases and conditions linked to altered receptor turnover include pancreatic cancer, NF1-related plexiform neurofibromas, allergic signaling and viral entry processes.
Conclusion
GO:0032801 receptor catabolic process defines the breakdown of receptor molecules that mediate cellular responses to hormones, neurotransmitters, drugs and intracellular messengers. Its mechanisms span receptor activation, endosomal sorting, autophagy-linked delivery and lysosomal degradation, with key roles for TFRC, autophagy machinery and disease-associated receptors such as PTPRS and FcεRI. Because receptor catabolism shapes signal duration and cellular adaptation, it is relevant to cancer, neurofibromatosis-related biology, immune signaling and viral entry. Studying this process requires integrated experimental approaches, including imaging, proteomics, transcriptomics and CRISPR-based editing. By combining these tools, researchers can define causal genes, resolve stage-specific mechanisms and identify therapeutic opportunities linked to receptor catabolic process.
References
- 1. Huang X et al.. 2021. LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling.. Nat Commun 12(1):3830 PMID: 34158490
- 2. Puri C et al.. 2025. Transferrin receptor controls both autophagosome formation and closure via phosphatidylinositol 3-phosphate synthesis.. Dev Cell 60(20):2715-2729.e8 PMID: 40543506
- 3. Del Mármol J et al.. 2021. The structural basis of odorant recognition in insect olfactory receptors.. Nature 597(7874):126-131 PMID: 34349260
- 4. Liu Y et al.. 2021. Regulatory mechanisms of mitophagy in yeast.. Biochim Biophys Acta Gen Subj 1865(5):129858 PMID: 33545228
- 5. Li Y et al.. 2024. Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas.. Cancer Lett 599:217151 PMID: 39094827
- 6. Deng M et al.. 2024. Structural insights into the high-affinity IgE receptor FcεRI complex.. Nature 633(8031):952-959 PMID: 39169187
- 7. Arbogast F et al.. 2025. Epidermal maintenance of Langerhans cells relies on autophagy-regulated lipid metabolism.. J Cell Biol 224(2) PMID: 39535446
- 8. Yan H et al.. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.. Elife 3 PMID: 25409679
